Shirin Shafazand, M.D., MS
General Information

Appointments
Contact
- Office: 305-243-7838
- Fax: 305-243-6372
Languages
- English
- Farsi
Certifications
- American Board of Internal Med-Sleep Medicine
- American Board of Internal Med-Critical Care Medicine
- American Board of Internal Med-Pulmonary Disease
Specialties
- Sleep Medicine - Internal Medicine
- Pulmonary Disease - Internal Medicine
- Internal Medicine
Roles
- Associate Professor of Medicine
- Voluntary Professor, Department of Public Health Sciences
Clinical Interests
Research Interests
Health Related Quality of Life, Outcomes Research, Health policy and economics, Sleep disorders in women, Sleep disorders in transplant patients, OSA treatment compliance, Pulmonary Hypertension trials.
Education
Undergraduate
University of Toronto
Graduate
University of Toronto
Residency
University of Toronto
Fellowship
Stanford University
Biography
Shirin Shafazand, MD, MS is an Associate Professor of Medicine and the director of the pulmonary hypertension clinics at University of Miami. She completed training in pulmonary and critical care medicine and has a Master of Science degree in Health Research and Policy both from Stanford University. Dr. Shafazand is certified as a sleep specialist by the American Board of Sleep Medicine and is also a board certified specialist in internal medicine and pulmonary and critical care medicine. She is a member of AOA and a number of medical societies including the ACP, American College of Chest Physicians, American Thoracic Society, and the Royal College of Physicians of Canada. Dr. Shafazand is a Reviewer for Journal Chest, Journal of Critical Care, European Respiratory Journal and is the author of numerous scientific publications. She is the Associate Editor for the Annals of American Thoracic Society, and Journal of Clinical Sleep Medicine. She specializes in the care of patients with sleep disorders, pulmonary hypertension and cares for those who are pre and post lung transplantation. Her research interests lie in determining outcomes of sleep disorders in specialized populations such as Parkinson's disease and spinal cord injury.